A factor IX deficiency that gets better at puberty: where the mutation sits, why androgens rescue it, the one variant that never recovers, and the DM Hematopathology entrance question it inspired.

- What it is: a rare X-linked form of haemophilia B caused by mutations in the factor IX (F9) gene promoter
- Childhood: factor IX activity from below 1% to about 13%, with typical haemophilia bleeding
- After puberty: factor IX rises to about 50โ70% and bleeding largely stops
- Why: androgens act through an androgen-responsive element in the promoter to restore transcription
- Exception: haemophilia B Brandenburg (mutation at position โ26) disrupts that element and does not improve
Mechanism
Most haemophilia B mutations alter the factor IX protein. In the Leyden form, the coding sequence is normal; point mutations sit in the promoter, roughly between nucleotides โ20 and +13. They block binding of liver transcription factors such as hepatocyte nuclear factor 4 (HNF4) and C/EBP, so little factor IX is made in childhood.
The promoter also contains an androgen-responsive element (a steroid receptor binding site). As testosterone rises at puberty, the androgen receptor binds this element and drives transcription despite the mutation, so factor IX levels climb towards normal.
The rescue depends on an intact androgen-responsive element. In haemophilia B Brandenburg the mutation at โ26 sits within that element, so androgens cannot act and the deficiency persists into adult life.
Clinical course
| Childhood | After puberty | |
|---|---|---|
| Factor IX activity | Below 1% to about 13% | About 50โ70% of normal |
| Bleeding | Haemarthroses, muscle and post-traumatic bleeding | Largely resolves |
| Treatment | Factor IX replacement as for other haemophilia B | Often none; cover for major surgery if levels are low |
Laboratory and management
- Coagulation screen: prolonged APTT with normal PT, corrected by mixing with normal plasma.
- Factor assay: low factor IX in childhood; repeat after puberty to document recovery.
- Genetics: F9 sequencing that includes the promoter region identifies the Leyden mutation and predicts improvement, which guides counselling and long-term prophylaxis plans.
- Carriers: X-linked inheritance; female carriers may have mildly low levels.
The classic stem is a boy with haemophilia B whose bleeding stops after puberty. The answer is a promoter mutation rescued by the androgen (steroid) receptor; anabolic steroids have been used to raise factor IX in some patients.
Practice questions
A boy with severe haemophilia B stops bleeding after puberty, when his factor IX rises to 60%. Which receptor explains the recovery?
Show answer
Where are the mutations in haemophilia B Leyden located?
Show answer
Why does haemophilia B Brandenburg not improve after puberty?
Show answer
- Haemophilia B Leyden is caused by F9 promoter mutations, not coding mutations.
- Factor IX is very low in childhood and rises to about 50โ70% after puberty.
- Androgens act through an androgen-responsive element in the promoter.
- The Brandenburg variant (โ26) disrupts that element and does not improve.
Crossley M, Ludwig M, Stowell KM, et al. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science 1992;257:377โ379 ยท Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci USA 1992;89:6300โ6303 ยท Hoffbrand AV, Steensma DP. Hoffbrandโs Essential Haematology, 8th ed. Wiley-Blackwell; 2019
High-Yield, Board-Style Image MCQs & Interactive Whole Slide Images
High-resolution virtual microscopy with questions aligned to ABP, FRCPath, NEET-SS, DM Hematopathology and MD/DNB.



Leave a Reply